{
"NDC": {
"NDCCode": "63739-203-03",
"PackageDescription": "18 CUP, UNIT-DOSE in 1 CASE (63739-203-03) / 5 mL in 1 CUP, UNIT-DOSE (63739-203-01) ",
"NDC11Code": "63739-0203-03",
"ProductNDC": "63739-203",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Atovaquone",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Atovaquone",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20240708",
"EndMarketingDate": "20260228",
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA214272",
"LabelerName": "McKesson Corporation dba SKY Packaging",
"SubstanceName": "ATOVAQUONE",
"StrengthNumber": "750",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Antimalarial [EPC], Antiprotozoal [EPC]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2026-03-03",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": null,
"StartMarketingDatePackage": "20240708",
"EndMarketingDatePackage": "20260228",
"SamplePackage": "N"
}
}